“…First, although direct T 2 or T 2 * quantification using multiecho images at different echo times would have been more accurate for quantifying the T 2 or T 2 * shortening effect of SPIO in the liver, we used RSL values calculated using the signal intensities of the liver, as seen on single‐echo images before and after SPIO enhancement, due to the limited gradient power and long data acquisition time of our animal MR scanner. However, our imaging method has been widely used in clinical practice and for research and is also thought to be a reliable method for estimating the degree of hepatic SPIO‐enhancement . Second, in our study our NAFLD animal model did not show the very early stage of NAFLD, ie, mild hepatic steatosis without insulin resistance, as the ob/ob mice, which are genetically prone to obesity and insulin resistance, developed moderate to severe hepatic steatosis and metabolic features of NAFLD as early as 3 weeks after beginning their HFHC diet.…”